Delmas C V L, Munro J, Bérard M, Di Paolo T, Morissette M, Tremblay M E, Parent A, Parent M
CERVO Brain Research Center and Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada.
Centre de recherche du CHU de Québec and Faculty of Pharmacy, Université Laval, Quebec City, QC G1V 4G2, Canada.
Neurobiol Dis. 2025 Jul;211:106938. doi: 10.1016/j.nbd.2025.106938. Epub 2025 May 2.
The subthalamic nucleus (STN), the main driving force of the basal ganglia, is innervated by brainstem serotonin (5-HT) neurons with highly plastic axonal arborization. A pathologically-induced rearrangement of the ascending 5-HT projections could contribute to the disrupted firing pattern of STN neurons observed in Parkinson's disease (PD). This light and electron microscope study was designed to characterize the neuroadaptive changes of 5-HT inputs to the different functional territories of the STN in four cynomolgus monkeys (Macaca fascicularis) rendered parkinsonian by systemic injections of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and four control animals. Using an unbiased stereological approach, we report a significant decrease of the density of 5-HT axon varicosities immunolabeled for the 5-HT membrane transporter (SERT), across all STN functional territories of MPTP-treated monkeys. In MPTP-treated animals, the SERT+ axon varicosities are larger than in control monkeys. In both experimental conditions they are only partially synaptic. A preserved length of 5-HT axons in the STN along with a conserved number of 5-HT neurons in the dorsal raphe nucleus is observed. Overall, our results indicate that, in parkinsonian monkeys, the 5-HT axons projecting to the STN are preserved but endowed with significantly less axon varicosities. Such neuroadaptive change could lead to a lower ambient level of 5-HT in this basal ganglia component, representing a compensatory mechanism designed to cope with the hyperexcitability of STN neurons that is known to occur in PD.
丘脑底核(STN)是基底神经节的主要驱动力,由具有高度可塑性轴突分支的脑干5-羟色胺(5-HT)神经元支配。病理性诱导的5-HT上行投射重排可能导致帕金森病(PD)中观察到的STN神经元放电模式紊乱。本光镜和电镜研究旨在表征4只经全身注射1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)而患帕金森病的食蟹猴(猕猴)以及4只对照动物中,5-HT输入到STN不同功能区域的神经适应性变化。使用无偏倚的立体学方法,我们报告在MPTP处理的猴子的所有STN功能区域中,针对5-HT膜转运体(SERT)免疫标记的5-HT轴突膨体密度显著降低。在MPTP处理的动物中,SERT+轴突膨体比对照猴子中的更大。在两种实验条件下,它们仅有部分是突触性的。观察到STN中5-HT轴突的长度保留以及中缝背核中5-HT神经元数量守恒。总体而言,我们的结果表明,在患帕金森病的猴子中,投射到STN的5-HT轴突得以保留,但轴突膨体数量显著减少。这种神经适应性变化可能导致该基底神经节成分中5-HT的环境水平降低,这是一种旨在应对已知在PD中发生的STN神经元过度兴奋的代偿机制。